首页|老年冠心病病人血清MCP-1、GDF-15、GMP-140与冠状动脉狭窄程度的相关性

老年冠心病病人血清MCP-1、GDF-15、GMP-140与冠状动脉狭窄程度的相关性

扫码查看
目的:分析老年冠心病病人血清单核细胞趋化蛋白-1(MCP-1)、生长分化因子-15(GDF-15)和血小板颗粒膜蛋白-140(GMP-140)与冠状动脉狭窄程度的相关性。方法:选取中国人民解放军西部战区总医院2022年3月—2023年3月收治的97例老年冠心病病人为冠心病组,并选取同期60名健康体检者为对照组,检测血清MCP-1、GDF-15、GMP-140水平。按照冠心病病人冠状动脉狭窄程度分为轻度狭窄组、严重狭窄组,比较轻度狭窄组、严重狭窄组血清MCP-1、GDF-15、GMP-140水平,采用Spearman相关性分析法分析血清MCP-1、GDF-15、GMP-140水平与冠状动脉狭窄程度的相关性,并使用受试者工作特征曲线(ROC)分析MCP-1、GDF-15、GMP-140评估冠状动脉狭窄程度的效能。结果:冠心病组血清MCP-1、GDF-15、GMP-140水平高于对照组,差异均有统计学意义(P<0。05)。严重狭窄组血清MCP-1、GDF-15、GMP-140水平高于轻度狭窄组,差异均有统计学意义(P<0。05)。Spearman相关性分析显示,冠心病病人血清MCP-1、GDF-15、GMP-140水平与冠状动脉狭窄程度呈正相关(P<0。05)。ROC曲线分析显示,MCP-1、GDF-15、GMP-140联合评估冠状动脉狭窄程度的曲线下面积为0。887,敏感度、特异度分别为88。89%、88。46%。结论:冠心病病人血清MCP-1、GDF-15、GMP-140水平显著升高,且与冠状动脉狭窄程度进展密切相关,联合检测血清MCP-1、GDF-15、GMP-140可有效评估冠状动脉狭窄程度。
Correlation between Serum MCP-1,GDF-15,GMP-140 and Degree of Coronary Artery Stenosis in Elderly Patients with Coronary Heart Disease
Objective:To analyze the correlation between serum levels of monocyte chemoattractant protein-1(MCP-1),growth differentiation factor-15(GDF-15),and platelet granular membrane protein-140(GMP-140)and the severity of coronary artery stenosis in elderly patients with coronary heart disease.Methods:Ninety-seven elderly patients with coronary heart disease admitted to General Hospital of the Western Theater Command of People's Liberation Army from March,2022 to March,2023,and 60 healthy people in the same period were selected and included in coronary heart disease group and control group respectively.Serum MCP-1,GDF-15,and GMP-140 were detected.According to the degree of coronary artery stenosis,patients with coronary heart disease were divided into mild stenosis group and severe stenosis group,and the differences of serum levels of MCP-1,GDF-15,and GMP-140 between the two groups were compared.Spearman correlation analysis was used to calculate the correlation between serum MCP-1,GDF-15,and GMP-140 and the degree of coronary artery stenosis,and receiver operating characteristic curve(ROC)was used to analyze the efficacy of MCP-1,GDF-15,and GMP-140 for evaluating the degree of coronary artery stenosis.Results:Serum MCP-1,GDF-15,and GMP-140 in coronary heart disease group were higher than those in control group,and the difference was statistically significant(P<0.05).Serum MCP-1,GDF-15,and GMP-140 in severe stenosis group were higher than those in mild stenosis group,and the difference was statistically significant(P<0.05).Spearman correlation analysis showed that serum MCP-1,GDF-15,and GMP-140 were positively correlated with the degree of coronary artery stenosis(P<0.05).ROC curve showed that the area under the curve(AUC)of MCP-1,GDF-15,and GMP-140 combined for evaluating the degree of coronary artery stenosis was 0.887,and the sensitivity and specificity were 88.89%and 88.46%respectively.Conclusion:Serum levels of MCP-1,GDF-15,and GMP-140 significantly increased in patients with coronary heart disease,and the elevation of these indexs is closely associated with the progression of coronary artery stenosis.The detection of serum MCP-1,GDF-15,and GMP-140 can provide a reliable reference for evaluating the degree of coronary artery stenosis.

coronary heart diseasethe elderlymonocyte chemoattractant protein-1growth differentiation factor-15platelet granular membrane protein-140

张曦月、杨源瑞、何楠、蔡羚琴

展开 >

中国人民解放军西部战区总医院(成都 610083)

冠心病 老年人 单核细胞趋化蛋白-1 生长分化因子-15 血小板颗粒膜蛋白-140

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(6)
  • 18